Aytu bioscience, inc (AYTU)
Income statement / Yearly
Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Aug'13Aug'12Aug'11
Product revenue, net

7,314

3,660

-

-

-

-

-

-

-

License revenue, net

5

0

-

-

-

-

-

-

-

Product revenue, net

-

-

3,221

-

-

-

-

-

-

Revenues
Product and service revenue

-

-

-

2,050

-

-

-

-

-

Product and service revenue

-

-

-

-

176

-

-

-

-

License revenue

-

-

-

511

85

58

-

-

-

Total revenue

7,320

3,660

3,221

2,562

261

58

-

-

-

Operating expenses
Cost of sales

2,202

2,050

1,417

957

88

-

-

-

-

Research and development

589

167

959

6,127

3,219

3,933

-

-

-

Research and development - related party (Note 9)

-

-

387

191

203

125

-

-

-

Selling, general and administrative

18,887

17,732

17,442

8,517

3,980

-

-

-

-

Selling, general and administrative - related party

351

0

165

307

311

-

-

-

-

Impairment of intangible assets

0

1,856

1,265

7,500

0

-

-

-

-

Amortization of intangible assets

2,136

1,553

1,708

664

90

-

-

-

-

Total operating expenses

24,166

23,360

23,346

24,266

7,894

-

-

-

-

Revenue

-

-

-

-

-

-

1

1

0

Professional fees

-

-

-

-

-

-

18

17

44

Contributed services, related party (Note 3)

-

-

-

-

-

-

6

7

4

General and administrative

-

-

-

-

-

2,346

29

33

84

Loss from operations

-16,846

-19,700

-20,125

-21,704

-7,632

-6,346

-52

-56

-133

Other (expense) income
Other (expense), net

535

749

2,534

5,491

114

-

4

3

3

Unrealized gain on investment

-

-

-

-

0

-

-

-

-

(Loss) on investment

-

-

-61

-971

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

54

58

133

Other gain

-

-

0

-

-

-

0

0

0

Gain from warrant derivative liability

-9,830

6,277

212

-12

0

-

-

-

-

Gain from warrant derivative liability

80

3,983

-

-

-

-

-

-

-

Total other (expense) income

-10,285

9,512

-2,383

-6,475

-114

-

-4

-3

-3

Interest (expense) income

-

-

-

-

-

-45

-

-

-

Net loss, before income tax

-

-

-

-

-7,747

-6,392

-

-

-

Deferred income tax benefit

-

-

-

-

-23

-813

-

-

-

Net loss

-27,131

-10,187

-22,508

-28,180

-7,723

-5,578

-57

-59

-136

Weighted average number of common shares outstanding

7,794

665

466

87

767

6,949

4,884

4,811

-

Basic and diluted net loss per common share

-3.48

-15.31

-48.30

-323.70

-10.07

-0.80

-0.01

-0.01

-0.03

Basic and diluted weighted average common shares outstanding

-

-

-

-

-

-

-

-

4,079